Article

Dr. Gary Novack: State of glaucoma pharmaceuticals, what future holds

Gary D. Novack, PhD, president of PharmaLogic Development, co-moderated an industry panel discussion on glaucoma pharmaceuticals Friday during Glaucoma 360. Watch Dr. Novack outline the state of glaucoma drug therapy and where the future is headed.

Gary D. Novack, PhD, president of PharmaLogic Development, co-moderated an industry panel discussion on glaucoma pharmaceuticals Friday during the 4th Annual Glaucoma 360 New Horizons Forum. Watch as Dr. Novack outlines the state of glaucoma drug therapy and where the future is headed.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
Related Content
Retinal thinning may serve as early biomarker of genetic risk for schizophrenia
May 2nd 2025

Retinal thinning may serve as early biomarker of genetic risk for schizophrenia

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

ZEISS unveils new AI-driven research data platform
May 2nd 2025

ZEISS unveils new AI-driven research data platform

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Private practice: Insights into the challenges and strategies of practice management
May 1st 2025

Private practice: Insights into the challenges and strategies of practice management

FDA clears expansion of amblyopia treatment from Luminopia to include 8 to 12 year olds
May 1st 2025

FDA clears expansion of amblyopia treatment from Luminopia to include 8 to 12 year olds

© 2025 MJH Life Sciences

All rights reserved.